Sika continues to expand its portfolio of high-performance flooring solutions with a service offering designed specifically to meet the wide-ranging needs of pharmaceutical manufacturers. Scheduled to be unveiled at Interphex, to be held April 17-19 in New York City, the service will enable life sciences companies to assert greater control over the design, construction, maintenance and cost of existing and new facilities.
Sika is making available to architects, designers and managers of pharmaceutical facilities its network of technical, design and construction experts to create systems that address the unique demands pharma environments. Working along with Sika's installation partners, companies can benefit from time- and cost-saving installation technology, allowing pharmaceutical manufacturers to assert greater control over shutdown and production start dates.
In applications for cleanrooms and other areas requiring the most stringent environmental monitoring, Sika has developed a hygienic envelope system that integrates floors, walls and ceilings into a seamless, non-porous, chemical resistant barrier. This technique facilitates the ease and speed of sanitization and prevents liquids from compromising the substrate which could create the possibility of back side mold growth.
"Controlled spaces in biologics, pharmaceutical, medical device and clean production facilities are subject to both local and global inspections against rigorous standards," said Jim Hendley, life sciences vertical market manager, Sika Corp. USA. "At Sika, we believe it is essential to integrate the designer, manufacturer and facility manager in to a team, to understand these issues and provide a holistic, no-surprise, flooring and-importantly-full-envelope system that maintain performance expectations, sterility and construction schedules."
This approach ensures the facility owner greater control over the performance of the system through its lifetime and prevents failures with solutions that offer superior design properties to meet the rigorous standards of a pharmaceutical manufacturing facility. Sika systems offer exceptional durability and longevity with high levels of resistance to chemical, mechanical and impact resistances so when facilities are inspected they not only are sanitary, they look sanitary. Additionally, Sika's cleanroom systems release 1,000 times fewer emissions than standard low-VOC systems.
Interphex attendees interested in learning more about how life science companies can better control the environmental conditions of their developmental, production and logistical areas, are invited to attend Jim Hendley’s Interphex Technical Theater presentation at 3 p.m. on April 17.
For more information, visit usa.sika.com.